Cargando…
Immune checkpoint inhibitors in elderly patients treated for a lung cancer: a narrative review
This article is a review of the literature concerning efficacy and safety of immune checkpoint inhibitors (ICIs) in the elderly population. In the past decade, immunotherapy deeply changed the treatment paradigm of lung cancer in particular in advanced non-small cell lung cancer (aNSCLC). Thus, ICIs...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264351/ https://www.ncbi.nlm.nih.gov/pubmed/34295694 http://dx.doi.org/10.21037/tlcr-20-1239 |